Ullman Quoted in NutraIngredients-USA
September 21, 2017 |Marc Ullman weighed in on a story in NutraIngredients-USA.com entitled, “Amarin’s ITC case against omega-3s players decried as attempt to corner EPA market.”
The article discusses how, as the concentration levels of omega-3 dietary supplement products have steadily risen, pharmaceutical manufacturer Amarin has moved to protect its competitive turf by filing a trade complaint against a number of suppliers and finished goods brands. Some trade groups alleged the move was a de-facto attempt to create a near monopoly in high concentrate EPA products.
To read the article, click here.
